Bill Wexler's Dog Pound Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound

REFR 1.330

-0.7%

Jan 6 3:31 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kelly who wrote (4597)	11/2/1999 12:07:00 PM
From: JDN	of 10293

Dear Kelly and all: In fairness of presentation I agree. I own a biotech stock that has been VERY successful in bringing out products such as the widest used drug in treating AIDS a super drug for treating hepatitus BUT they signed an agreement with GLAXO which resulted in much of the profits being siphoned off to GLAXO so stock hasnt done anything for me. However, going forward now that they are financially strong they are attempting to wean themselves from GLAXO and market and distribute their FUTURE drugs themselves. Much riskier but if they are successful stock SHOULD move. I never took the time to really understand the GUMM/GELTECH relationship but if I were a serious investor in GUMM I would want to make sure that I understood it well. JDN

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next